Charlie Badham, Corporate Development, 4D pharma, spoke to Lu Rahman about the growing significance of microbiomics in the quest for new therapeutics   LR: How important are microbiomics in the development of new therapeutics and how does understanding gut bacteria help us find treatments for new diseases? CB: The microbiome and live biotherapeutic products (LBPs) […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!